Investment Summary

Eight Roads Invests In Leocare

On November 23, 2021, private equity firm Eight Roads invested in insurance company Leocare

Investment Highlights
  • This is Eight Roads’ 1st transaction in the Insurance sector.
  • This is Eight Roads’ 4th transaction in France.

Investment Summary

Date 2021-11-23
Target Leocare
Sector Insurance
Investor(s) Eight Roads
Deal Type Venture

Target

Leocare

Paris, France
Leocare is a French neo-insurer that specialises in automotive, home and smartphone insurance. Leocare was founded in 2017 and is based in Paris, France.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


DEAL STATS #
Overall 267 of 293
Sector: Insurance M&A 1 of 1
Type: Venture M&A Deals 243 of 266
Country: France M&A 4 of 6
Year: 2021 M&A 27 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-18 MayaData

San Jose, California, United States

MayaData is a developer of software for the use of Kubernetes as a data layer. MayaData sponsors two Cloud Native Computing Foundation (CNCF) projects, OpenEBS - the leading open-source container attached storage solution - and Litmus - the leading Kubernetes native chaos engineering project. MayaData was founded in 2010 and is based in San Jose, California.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-09 K36 Therapeutics

Cambridge, Massachusetts, United States

K36 Therapeutics is a biotechnology company developing breakthrough therapies for the unmet medical needs of cancer patients worldwide. K36 Therapeutics was founded in 2021 and is based in Cambridge, Massachusetts.

Buy -